Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03052816 · ClinicalTrials.gov registry record · Phase 4

Ice T Postoperative Multimodal Pain Regimen in FPMRS Surgery

A Phase 4 study, sponsored by University Hospitals Cleveland Medical Center.

Completed
Registry status
Phase 4
Development phase
66
Enrollment target

NCT03052816 is a Phase 4 study that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 66 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03052816, a Phase 4 study, has completed, sponsored by University Hospitals Cleveland Medical Center.

COMPLETED
Registry status
Phase 4
Development phase
66 participants
Enrollment target

Study Summary

The purpose of this randomized controlled trial is to determine whether, "ICE-T," a novel multimodal postoperative pain regimen composed of around the clock ice packs, toradol, and tylenol, has improved pain control intake compared to the standard postoperative pain regimen in patients undergoing vaginal pelvic floor reconstructive surgery.

Interventions

  • DRUG Ice T
  • DRUG Motrin/Percocet/Dilaudid for breakthrough

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2017-04-01
Est. Completion 2018-06-30
Phase Phase 4

What the Registry Record Tells You About NCT03052816

The ClinicalTrials.gov registry entry for NCT03052816 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Ice T is the first listed.

NCT03052816 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03052816 about?

NCT03052816 is a clinical study titled "Ice T Postoperative Multimodal Pain Regimen in FPMRS Surgery". The purpose of this randomized controlled trial is to determine whether, "ICE-T," a novel multimodal postoperative pain regimen composed of around the clock ice packs, toradol, and tylenol, has improved pain control intake compared to the standard postoperative pain regimen in patients undergoing va...

What is the current status of trial NCT03052816?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 66 participants. The study started on 2017-04-01. Estimated completion is 2018-06-30.

What interventions are being tested in trial NCT03052816?

The interventions under investigation include: Ice T (DRUG), Motrin/Percocet/Dilaudid for breakthrough (DRUG).

Who is sponsoring clinical trial NCT03052816?

This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.